MatrixDB

MatrixDB is a freely available database focused on interactions established by extracellular matrix proteins, proteoglycans and polysaccharides

Source Last Updated
MatrixDB May 10, 2022
Displaying entries 326 - 350 of 440 in total
ID Label Method Experimental Species ▲ ChEBI Complex Portal GlyTouCan ID KEGG ID LIPID MAPS UniProt IDs
MULT_15_mouse
Mus musculus CPX-3027
MULT_96_mouse
Mus musculus CPX-451
MULT_53_mouse
Mus musculus CPX-3006
MULT_12_mouse
Mus musculus CPX-2980
MULT_73_mouse
Mus musculus CPX-3127
MULT_28_mouse Laminin-121
  • unspecified role
  • unspecified role
Mus musculus CPX-3010
MULT_46_mouse
Mus musculus CPX-2996
MULT_76_mouse
Mus musculus CPX-3134
MULT_55_mouse
Mus musculus CPX-3030
MULT_42_VAR2_mouse
Mus musculus CPX-2968
PFRAG_1_mouse Endostatin
  • bait
  • prey
  • unspecified role
  • bait
  • prey
  • unspecified role
Mus musculus
MULT_23_mouse
Mus musculus CPX-1916
MULT_44_mouse
Mus musculus CPX-2994
PFRAG_5_mouse
Mus musculus
PFRAG_12_mouse
Mus musculus
MULT_17_mouse
Mus musculus CPX-3131
MULT_27_mouse
Mus musculus CPX-3009
MULT_63_mouse
Mus musculus CPX-3121
PFRAG_40_mouse
Mus musculus
MULT_31_VAR1_mouse
Mus musculus CPX-3013
MULT_29_mouse
Mus musculus CPX-3011
MULT_30_VAR2_mouse
Mus musculus CPX-3164
MULT_9_mouse Collagen-II
  • neutral component
  • unspecified role
  • neutral component
  • unspecified role
Mus musculus CPX-2957
MULT_40_mouse
Mus musculus CPX-3021
MULT_1_mouse Laminin-111
  • neutral component
  • prey
  • unspecified role
  • neutral component
  • prey
  • unspecified role
Mus musculus CPX-3008

About Release Notes Help Feedback

International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.4.0

Last updated: December 8, 2025